Tests to assess the risk of sudden death and early detection of kidney cancer have been created in Russia. They are currently being prepared for implementation. This was announced by Konstantin Kotenko, Director of the Petrovsky Russian Scientific Center for Surgery, at the St. Petersburg International Economic Forum.
As part of predictive genetics, we have developed and are preparing for implementation tests to determine the risk of sudden death, early detection of oncological diseases of the kidneys and other diseases.
He also announced a method for treating arthrosis in the thoracic joints using the patient's own cells. In outpatient settings, in six hours, the patient receives therapy that restores cartilage and stops the progression of the disease in the early and late stages. This is an alternative to endoprosthetics.
We have completed our work and have already made clinical recommendations. We plan to register a medical device for this technology in 2026, and such treatment will become widely available to our citizens in any medical organization in our country.
He cited statistics: in Russia, about 1.5 million people suffer from arthrosis of the joints.
Kotenko also touched upon the topic of gene therapy for aging. In his opinion, this technology can control the activity of genes, opening up new opportunities for treatment.
Another promising area of aging biology is the development of biomedical products containing exosomes. These are extracellular vesicles with biological markers.
The first such product was developed at Moscow State University for the treatment of male infertility.
The scientist said that he and his colleagues are working on creating a drug for the prevention and treatment of age-related muscle loss - sarcopenia. There are already interesting preliminary results: exosomes can both accelerate the aging of young cells and rejuvenate aging ones. They plan to develop a means for building muscle mass based on this effect.
Earlier in Russia, the first cancer screening system based on artificial intelligence, Oncopro, was registered. This system, unlike traditional methods, which are used only when symptoms appear, will allow assessing individual risk. This is especially important for patients who do not have obvious clinical signs.
Read materials on the topic:
AI will be trained in Russia to create cancer vaccines
The only drug in Russia against cancer based on the virus has passed the first tests
A facility for treating the most complex types of cancer has been created in Novosibirsk